StreetAlpha.app
Home › Stocks › RNA

Atrium Therapeutics, Inc. (RNA)

$6.48
▲ +0.78%
LAST CLOSE · NOV 17

Atrium Therapeutics, Inc. (RNA) tracked by StreetAlpha. It last closed at $6.48 on Nov 17, up 0.78% on the day. RNA reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 2 analysts is $17.50 (+170.1% from the last close), with a high of $20.00 and a low of $15.00.

AI Auto Pilots
Is RNA in one of our four AI portfolios? Sign in free to see
Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
-$1.00
$4.3M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated RNA in the past 90 days, not enough for a consensus
Average 12-month target
$17.50
▲ 170.1% upside

Based on 2 analysts who set a price target on RNA in the past 90 days. The average target is $17.50, with a high of $20.00 and a low of $15.00, compared with the last close of $6.48.

Low $15.00Avg $17.50High $20.00
Blue marker: last close $6.48
Highest target$20.00
Average target$17.50
Lowest target$15.00
Latest rating changes
HC Wainwright & Co.Target lowered
Oct 28Buy$25 → $20
Roth CapitalInitiated
Oct 22Buy$15
HC Wainwright & Co.Reiterated
Aug 14Buy$25
HC Wainwright & Co.Initiated
Aug 6Buy$25
Cantor FitzgeraldInitiated
Jun 18Buy$25
DateFirmActionRatingPrice target
Oct 28HC Wainwright & Co.Target loweredBuy$25 → $20
Oct 22Roth CapitalInitiatedBuy$15
Aug 14HC Wainwright & Co.ReiteratedBuy$25
Aug 6HC Wainwright & Co.InitiatedBuy$25
Jun 18Cantor FitzgeraldInitiatedBuy$25
Loading…

Technical Analysis

RNA · as of the Nov 17 close · updated after every close
Falling, oversold

The stock is 24% below its 20 day and 30% below its 50 day average. Momentum is weak (RSI 24), oversold. The nearest support is the 52 week low at $6.36, and the nearest resistance the Pivot at $6.62.

Short trendBearish
Long trendNot enough history
MomentumWeak
StretchOversold
VolatilityHigh, 7.0%/day
Key levels
$16.7752 week high+158.8%
$10.54100 day average+62.7%
$8.4050 day average+29.6%
$8.32Swing high (Oct 21)+28.4%
$8.0420 day average+24.1%
$6.80Pivot R1+4.9%
$6.62Pivot+2.2%
$6.48Last close
$6.3652 week low−1.9%
$6.30Pivot S1−2.8%
Indicators
RSI (14)23.57Oversold below 30Oversold
MACD-0.42Below its signal lineBearish
Stochastic3.4Near the bottom of its rangeOversold
ADX (14)27.2Trending down
Williams %R-95.3Oversold below −80, overbought above −20Oversold
CCI (20)-265.5Oversold below −100, overbought above 100Oversold
Rate of change−25.7%Change over 10 sessionsBearish
ATR (14)$0.46Typical daily range, 7.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for RNA

What happened before

See how RNA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in RNA in the last 90 days.

Loading…

See today’s whale options flow across the market →

RNA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●75 buying vs 76 selling
  • ▼Shares held by funds -12.8%
  • ▼Funds holding -8
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q1 '26Q2 '26Q3 '26
Funds holding
Q3 2026This quarterLast quarterChange
Funds holding148156−5.1%
In funds' top 1012−50.0%
Held by funds–––
New / increased26 / 4937 / 47−10.7%
Reduced / sold out41 / 3535 / 47−7.3%
Put/call ratio4.860.32+1430.2%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See RNA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether RNA is in one of them and how their past RNA trades turned out.

RNA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered RNA in an article yet. Here's the latest on the wider market.